Roivant Launches Aruvant Sciences and Roivant Foundation in Partnership with Cincinnati Children’s Hospital Medical Center

Aruvant’s pipeline anchored by RVT-1801, an investigational gene therapy for sickle cell disease and β-thalassemia Clinical data for RVT-1801 to be presented in an oral session at ASH on December 3rd Roivant...
November 26, 20180 DownloadsDownload